InvestorsHub on MSN
Kestra Medical publishes ASSURE defibrillator study showing 100% conversion of analyzable shock events
Kestra Medical Technologies (NASDAQ:KMTS) announced the publication of primary results from its ASSURE WCD Clinical Evaluation Post-Approval Study (ACE-PAS) in the Journal of Cardiovascular ...
A deep-learning electrocardiogram model accurately identified left ventricular systolic dysfunction in patients with left ...
PHILADELPHIA — Accelerometer-based atrial sensing with a novel, enhanced, automated algorithm in patients with atrioventricular block and a single-chamber leadless pacemaker in the right ventricle ...
Despite advances in defibrillation technology, shock-refractory ventricular fibrillation remains common during out-of-hospital cardiac arrest. Double sequential external defibrillation (DSED; rapid ...
A study of 2,290 liver transplant recipients found that continuous intraoperative complex premature ventricular contractions, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results